25.09.2018 - Boehringer Ingelheim has taken an option to buy all the shares of ViraTherapeutics, an Austrian biopharma that specializes in developing immunotherapy drugs based on oncolytic...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)
